Yokoyama J, Ohba S, Ito S, Fujimaki M, Yoshimoto H, Hanaguri M, Ikeda K. A feasibility study of lymphatic chemotherapy targeting sentinel lymph nodes of patients with tongue cancer (T3,N0,M0) using intra-arterial chemotherapy. Head Neck Oncol. 2012 Sep 9;4(2):60.
Conclusion
The THP-ADM concentrations in SLNs were significantly higher than in non-SNLs. This novel drug delivery system is feasible for lymphatic chemotherapy targeting SLNs in patients with cT3N0M0 oral cancer.
Source: Head and Neck Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Oral Cancer | Study